986 related articles for article (PubMed ID: 8541003)
1. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension.
Rossi E; Perazzoli F; Negro A; Sani C; Davoli S; Dotti C; Casoli MC; Regolisti G
Am J Hypertens; 1998 Jan; 11(1 Pt 1):8-13. PubMed ID: 9504444
[TBL] [Abstract][Full Text] [Related]
4. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
[TBL] [Abstract][Full Text] [Related]
5. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
[TBL] [Abstract][Full Text] [Related]
7. Relative glomerular hyperfiltration in primary aldosteronism.
Ribstein J; Du Cailar G; Fesler P; Mimran A
J Am Soc Nephrol; 2005 May; 16(5):1320-5. PubMed ID: 15800124
[TBL] [Abstract][Full Text] [Related]
8. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
[TBL] [Abstract][Full Text] [Related]
10. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism.
Maniero C; Fassina A; Seccia TM; Toniato A; Iacobone M; Plebani M; De Caro R; Calò LA; Pessina AC; Rossi GP
J Hypertens; 2012 Feb; 30(2):390-5. PubMed ID: 22179087
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
12. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
14. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
[TBL] [Abstract][Full Text] [Related]
16. Regulation of parathyroid hormone and vitamin D in essential hypertension.
Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
18. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.
Gennari C; Nami R; Gonnelli S
Miner Electrolyte Metab; 1995; 21(1-3):77-81. PubMed ID: 7565468
[TBL] [Abstract][Full Text] [Related]
19. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F
Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
